RECRUITINGOBSERVATIONAL
Minimally Invasive Treatments of the Thyroid
Multicenter International Prospective Analysis on Minimally Invasive Treatments of the Thyroid (MIPA- MITT) of of Micropapillary Thyroid Carcinoma
About This Trial
This is a prospective cohort study to test Minimally Invasive Treatments of the Thyroid (MITT) as potential alternative to surgery in patients with Papillary Thyroid MicroCarcinoma (PTMC)
Who May Be Eligible (Plain English)
Who May Qualify:
- Patients \> 18years
- Patients with diagnosis of papillary thyroid microcarcinoma, citologically proven, suitable for MITT.
- Written willing to sign a consent form must be signed and dated by the patient and the investigator prior to inclusion.
- Patients must be accessible for follow-up
Who Should NOT Join This Trial:
- Tumors \> 1 cm, other citological type, refusal of MITT, unsuitable for MITT, unmanageable coagulative disorders
- Patients with psychiatric, addictive, or any disorder, which compromises ability to give willing to sign a consent form for participation in this study
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Patients \> 18years
* Patients with diagnosis of papillary thyroid microcarcinoma, citologically proven, suitable for MITT.
* Written informed consent must be signed and dated by the patient and the investigator prior to inclusion.
* Patients must be accessible for follow-up
Exclusion Criteria:
* Tumors \> 1 cm, other citological type, refusal of MITT, unsuitable for MITT, unmanageable coagulative disorders
* Patients with psychiatric, addictive, or any disorder, which compromises ability to give informed consent for participation in this study
Treatments Being Tested
PROCEDURE
image-guided thermal ablation
image-guided thermal ablation in patients with diagnosis of micropapillary thyroid carcinoma
Locations (1)
European Institute of Oncology
Milan, Italy